Bloodwork Panel Planner
Plan consolidated blood work panels based on your peptide protocol. Get recommended biomarkers, testing frequency, and lab panel suggestions organized by protocol phase โ baseline, mid-cycle, and post-cycle.
Select your peptides and protocol phase to generate a consolidated bloodwork panel with reference ranges, cost estimates, and a testing timeline.
1
Select Your Peptides
2
Select Protocol Phase
Baseline
Before starting
Mid-Protocol
4-6 weeks in
Post-Protocol
2-4 weeks after stopping
Bloodwork Panel - PathToPeptides
3
Your Consolidated Panel
| Test | Required By | Reference Range | What to Watch | Est. Cost |
|---|
Testing Timeline
General
Male
Female
| Marker | Normal Range | Unit | Notes |
|---|
🧬
Want personalized biomarker interpretation? BioRoot AI offers a free functional wellness assessment that analyzes your lab results in context and generates a personalized care plan based on root-cause analysis.
Frequently Asked Questions
What bloodwork do I need before peptides?
Baseline bloodwork before starting peptides typically includes a Comprehensive Metabolic Panel (CMP), Complete Blood Count (CBC), Lipid Panel, and category-specific markers. GH peptides require IGF-1, GLP-1 agonists need HbA1c and pancreatic enzymes, and hormonal peptides require a full hormone panel including Total/Free Testosterone, Estradiol, LH, FSH, and SHBG. Use the planner above to generate your exact panel based on the peptides you plan to research.
How often should I get blood work on peptides?
Best practice is three phases: Baseline (before starting), Mid-Protocol (4-6 weeks in) to assess response and safety markers, and Post-Protocol (2-4 weeks after stopping) to confirm recovery. Some markers like liver enzymes and blood glucose may warrant more frequent monitoring if abnormalities are detected during the mid-protocol check.
What does IGF-1 tell me about GH peptides?
IGF-1 (Insulin-like Growth Factor 1) is the primary biomarker for assessing growth hormone secretagogue effectiveness. Since GH is released in pulses and has a short half-life, IGF-1 provides a more stable measure of overall GH activity. A rising IGF-1 from baseline indicates the GH peptide is successfully stimulating growth hormone release. Target ranges are typically 200-350 ng/mL for adults, though optimal levels vary by age and individual goals.
Related Tools & Resources
